Literature DB >> 16914399

Alteplase for acute stroke revisited: the first 10 years.

Patrick D Lyden, Kennedy R Lees, Stephen M Davis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16914399     DOI： 10.1016/S1474-4422(06)70530-0

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  5 in total

1.  A cost-effective rabbit embolic stroke bioassay: insight into the development of acute ischemic stroke therapy.

Authors:  Paul A Lapchak
Journal:  Transl Stroke Res       Date:  2015-02-01       Impact factor: 6.829

2.  A blinded, randomized study of L-arginine in small clot embolized rabbits.

Authors:  Paul A Lapchak; Jessica T Daley; Paul D Boitano
Journal:  Exp Neurol       Date:  2015-02-20       Impact factor: 5.330

Review 3.  Poised for success: implementation of sound conditioning strategies to promote endogenous protective responses to stroke in patients.

Authors:  Bethann McLaughlin; Jeff M Gidday
Journal:  Transl Stroke Res       Date:  2013-01-11       Impact factor: 6.829

4.  Influence of the 3K3A-activated protein C variant on the plasma clot lysis activity of t-PA and of t-PA on the variant's anticoagulant activity.

Authors:  L O Mosnier; J A Fernández; T P Davis; B V Zlokovic; J H Griffin
Journal:  J Thromb Haemost       Date:  2013-11       Impact factor: 5.824

Review 5.  Safety and efficacy of alteplase in the treatment of acute ischemic stroke.

Authors:  Giuseppe Micieli; Simona Marcheselli; Piera Angela Tosi
Journal:  Vasc Health Risk Manag       Date:  2009
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.